| Protein Biotherapeutic BioAnalysis, by Immunoaffinity LC‑MS: Latest Trends and Recommendations |
 |
| Event overview |
|
| The webinar will address the application of immunoaffinity LC-MS to regulated bioanalysis of biotherapeutics. Significant developments over the past three years have influenced this frontier of bioanalysis. The webinar will focus on the latest LC-MS technologies and techniques that are impacting the development of protein-based drugs. Approaches taken are in line with industry trends and regulatory expectations established around bioanalysis. |
|
| You will learn: |
|
| • |
|
About the strengths and weaknesses of LC-MS for protein bioanalysis |
| • |
|
How to apply modern LC-MS technology, including nano-flow LC and high resolution mass spectrometry (HRMS) |
| • |
|
Principles around holistic bioanalytical strategies for biotherapeutics |
|
|
|
|
| Presenters: |
|
|
 |
|
| Stephen Lowes |
| Senior Scientific Director, Bioanalysis and ADME Services, Q2 Solutions |
|
|
|
 |
|
| Barry Jones |
Associate Director, LCMS Biologics and Biomarkers,
Q2 Solutions |
|
|
|
| Moderator: |
|
|
 |
|
| Michael Christel |
| Managing Editor, Applied Clinical Trials |
|
|
|
|
|
|
|
|
|
 |
|
| Contact Us |
|
| Toll free: |
1 855.277.9929 |
| Direct: |
+1 919.998.7000 |
| International: |
+44 (0) 1506 814000 |
| Visit: |
www.Q2LabSolutions.com |
|
 |
|
|
 |
|
|
| Copyright ©2018 Q2 Solutions. All rights reserved. |
|
